IPG-6620

N/A

Report date: 2024/03/26 16:19:41
NMEFirst In Class

Base Information

Drug NameIPG-6620
Drug Alias NameIPG-6620IPG6620
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG-protein coupled receptor antagonists
TargetsG-protein coupled receptor
Therapy Area/IndicationsPeripheral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesNanjing Immunophage Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Immunophage Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsPeripheral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A